Souhaitez-vous accéder aux communiqués récents ?

€30 million Series D2 financing completed with participation from leading new and existing international investorsUp to €30 million financing facility secured from the European Investment Bank Paris,...

Financement de Série D2 de 30 millions d'euros avec la participation d'investisseurs internationaux de premier plan, nouveaux et historiquesMise en place d’une facilité de financement pouvant...

Data shows transvenous phrenic nerve stimulation reduces lung collapse and significantly increases availability of lungs that meet transplant criteria

Thanks to the support of the Linda and Mike Mussallem Foundation, Octane has launched the Octane Mussallem Cardiovascular Accelerator.

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical AUSTIN, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- FocalTherics...

Paris, France, June 15, 2026 – TISSIUM, a medical technology company pioneering biomorphic programmable polymers for tissue reconstruction, today announced its selection to the French Tech...

Paris, France, le 15 juin 2026 – TISSIUM, société de medtech spécialisée dans le développement de polymères programmables biomorphiques pour la reconstruction des tissus, annonce aujourd'hui son...

BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference

ThruFlo Endovascular completes seed financing to advance development of its novel bifurcated flow diverter for the treatment of bifurcation aneurysms.